CLINICAL COURSE, MANAGEMENT AND IN-HOSPITAL OUTCOMES
|
|
- Basil Patterson
- 5 years ago
- Views:
Transcription
1 Open Access Research Journal, Medical and Health Science Journal, MHSJ ISSN: (Print) (Online) Volume 5, 2011, pp CLINICAL COURSE, MANAGEMENT AND IN-HOSPITAL OUTCOMES OF ACUTE CORONARY SYNDROME IN CENTRAL ASIAN WOMEN The paper describes features history, risk factors and hospital management of acute coronary syndrome (ACS) in women of the Central Asia (829 ACS patients are included), and also comparison of hospital outcomes of ACS in groups of men and women. ACS in women in the Central Asia comprises features as more non Q-wave myocardial infarction frequency, smaller adherence to treatment of dyslipidemia, more obesity degrees. Women arrive to hospital average in 4 hours after men; have more percent of the atypical form. In-hospital outcomes in men and women significantly did not differ because of general tendency to late arriving to the hospital and small quantity of revascularization procedures. The reasons of differences between men and women in the region are mostly connected to social sphere (late arriving, non-treated dyslipidemia) than to physiological peculiarities. ALEKSEY NIKISHIN, RAVSHANBEK KURBANOV, MAHMUDJON PIRNAZAROV Republic Specialized Center of Cardiology, Uzbekistan Keywords: Acute coronary syndrome, in-hospital outcomes, risk factors, central Asian women. UDC: Introduction Ischemia is known to be the leading cause of women mortality throughout the world. Recent research on emergency cardiology has revealed some peculiar features of the symptoms, course and prognosis of acute coronary syndrome (ACS) in women (Shaw, 2006, Sheifer et al., 2000). It is generally accepted that ACS women are typically elder and, hence, more often have hypertension, diabetes. However, the researches conducted by Vaccarino (1999) and Hochman (1999) have revealed new facts based on analysis of numerous data indicating the difference between males and females in ischemia course that are not related to age. Another axiom of ACS in women postulates on worse inhospital and long-term prognosis, although it was not acknowledged in some research (Alfredsson at al., 2007.). There are data showing that women undergo invasive intervention less often (Rathore et al., 2002); on discharge they receive less evidence-based recommendations; women run higher risk of diabetes mellitus. Thus, the problem of acute coronary syndrome in females has many poorly studied aspects, in Central Asian region in particular. The objectives of the study were to reveal characteristics of history data, clinical course, in-hospital management of acute coronary syndrome in Central Asian women and to compare the in-hospital ACS outcomes in the groups of males and females. Material and methods This study included 829 patients with acute myocardial who were divided into two groups after randomization: group 1 (249patients) - the study group, which included patients of female sex central Asian origin, and group 2 (580 patients) - the control group, which included male patients with acute myocardial infarction. We identified Central Asian patients by their surnames and first names, and by using self-reported ethnicity and country of birth when available. Patients of Caucasian origin were excluded. To evaluate in-hospital outcome, the research involved patients with no age limitation who were admitted with the diagnosis acute myocardial infarction in The diagnosis was verified according to the WHO criteria. The risk factors, the standard hospital outcomes,
2 and also time characteristics (average arriving-to-hospital time, amount of the patients hospitalized at first 6 hours from ACS onset) were studied. Accumulation and correction of the findings were made using the standard software package of Microsoft Office Access 2003 for Windows XP. Reliability of the indicators difference was evaluated by χ² distribution test. The minimum sufficient significance was Р<0.05. Relative risk (RR) was calculated for each of the factors with 95 confidence interval (CI). Results In accordance with the research protocol, the involved patients were divided into two groups: group 1 included 249 females with acute myocardial infarction (AMI), group 2 was composed of 580 AMI males. Table 1 characterizes the patients and shows that two thirds of them were males (Table 1). TABLE 1. BASELINE CHARACTERISTICS Females Males n n Number Average age, years 65.0± ±3.7 Weight, kg 78.1± ±6.2 AMI with Q AMI without Q Previous MI Hypertension Duodenal ulcer Note: MI-myocardial infarction. The research showed, as expected, that AMI females were elder than males though the age difference was not significant (Р=0.43). Central Asian women, like men, suffered more often from AMI with Q. However, in males, AMI with Q was registered reliably more often (χ 2 =21.9; Р=0.0001). Previous MI (Р=0.78) and duodenal ulcer (Р=0.75) occurred in males and females with equal frequency. The symptoms of hypertension were reliably more often (Р=0.002) registered in females. In-hospital outcomes in the study groups (Table 2) did not differ significantly; they were lethal outcome (OR=1.18; 95 CI ), recurrent myocardial infarction (OR=0.77; 95 CI ), recurrent angina pectoris (OR=1.24; 95 CI ), hemorrhage (OR=0.93; 95 CI ), congestive heart failure (OR=1.04; 95 CI ), chronic heart failure (OR=1.75; 95 CI ). TABLE 2. IN-HOSPITAL OUTCOMES IN THE GROUPS Females n=249 Males n=580 n n Death Re-infarct Recurrent angina Bleeding Development of acute cardiac failure (Killip classes 2-3) Development of chronic heart failure
3 As the findings show, there were no significant differences between males and females in the depth of affection of the myocardium in AMI (with ECG wave Q); for this reason the criterion, which no doubt influenced the AMI course and prognosis, does not determine reliable gender-difference in the frequency of lethal outcomes in this disease. In our research the women were admitted to the Emergency Unit about four hours later than men (χ 2 =10.8; Р=0.001) that corresponds to the literature data. However, this fact did not impact significantly on the clinical outcomes as only patients were admitted in first six hours after the disease onset (Figure1). FIGURE 1. TIME OF PATIENT ADMISSION IN THE STUDY GROUPS 60 53, ,68 30,55 40,56 Females 20 Males 10 0 Admission mean time, hr Admitted in first 6 hr, When a coronary attack developed, males were seeking medical aid earlier than females. Thus, every second AMI male was admitted to hospital in first six hours after the attack while only females called in a physician in the early hours of the attack. Risk factors and specific therapy in the study groups To study the risk factors a database was formed using the information on 389 AMI patients from 14 hospitals of the region; they included 142 females and 274 males (Table 3). In women compared to men the significant part in the disease prognosis was played by reliably more often occurrence of hypertension (92.25), diabetes mellitus (28.87), dislipidemia (88.73), the untreated one (70.42). It is important that in males, the most significant risk factor is smoking (69.71; Р = ). Relative risks of stroke, instable angina, disrytnmia and CAFG in women are higher than in men. Both in the females group (χ 2 =13.7; Р = 0.001) and males group (χ 2 =28.9; Р =0.0001), the frequency of cases of treated arterial hypertension was reliably higher than untreated one while dislipidemia in both groups was mainly untreated (females - χ 2 =84.6; Р=0.0001; males - χ 2 =78.6; Р=0.0001). Analysis of the clinical course characteristics showed that relative risk of atypical pain syndrome is 1.6 times higher women than in men (Table 4). The ST segment elevation was found to be reliably more often registered in males (χ 2 =4.11; Р = 0.04). In AMI females, the relative risk of ST segment depression was higher than in males. Mean BP values (148.0 ± 2.94 mm Hg versus ± 3.78 mm. Hg in males) and previous MI (29.3 ± 0.15 kg/m 2 versus 27.9 ± 0.21 kg/m 2 in males) were reliably higher in the females
4 TABLE 3. PAIN THRESHOLD BEFORE STUMP FIXATION Females n=142 Males n=274 Relative risk (95 CI) P Diabetes mellitus ( ) 0.09 Hypertension (1, ) Treated ( ) Untreated ,11 ( ) 0.55 Dyslipidemia ( ) Treated ( ) Untreated ( ) 0.01 Smoking ( ) Previous MI ( ) 0.81 Ischemic stroke\tia ( ) 0.06 Prev. unstable angina ( ) 0.34 Prev. stable angina ( ) 0.47 CHF ( ) 0.88 Family history CVD ( ) 0.72 Dyshrythmia ( ) 0.14 PAD ( ) 0.73 PCI ( ) 0.29 CABG ( ) 0.86 Note: CHF-chronic heart failure, MI-myocardial infarction, TIA-transient ischemic attack, CVD-cardiovascular disease, PAD-peripheral artery disease, PCI -percutaneous coronary intervention, CABG- coronary artery bypass grafting. TABLE 4. CHARACTERISTICS OF AMI COURSE IN THE STUDY GROUPS Females n=142 Males n=274 Relative risk (95 CI) P Typical pain ( ) 0.18 Atypical pain ( ) 0.18 Dyspnea ( ) 0.14 ST elevated ( ) 0.04 ST depressed ( ) 0.09 LBBB ( ) 0.99 Note: LBBB-left bundle branch block. TABLE 5. THERAPY FOR AMI IN THE STUDY GROUPS Females, n=142 Males, n=274 P UFH Dose ± ± LMWH Dose 0.47.± ± * Thrombolysis Ca-antagonists * Nitrates Diuretics * Beta-blockers ACE inhibitors ARB Antiarrhythmics Lipid-lowering Insulin * Oral hypoglycaemic drugs Note: *P<0.05; UFH-unfractionated heparin; LMWH-low molecular weight heparin; ARB-angiotensin receptor blocker
5 The comparative analysis of the findings on the therapy prescribed during the patients stay in hospital indicated that females were more often prescribed calcium antagonists than males (χ 2 =4.99), the same was true about diuretics (χ 2 =11.2) and insulin (χ 2 =8.88) (Table 5). However, the doses of low-molecular heparin prescribed to males were reliably higher (Р=0.009). Discussion Most research, being the basis for all guidelines on AMI patient management, was conducted in Western countries (which of course include Australia and New Zealand) that have a number of peculiar features. Are their data comparable with the findings obtained in Central Asian countries having absolutely different social, economic and cultural status? Several studies of this problem have been already conducted, in particular the studies from South Asia (Gupta and Gupta, 1996; Yusuf et al., 1998) as well as reports of Chinese researchers JIANG (Jiang et al., 2006). They demonstrated that inhabitants of Far and Middle East have some peculiar features both in the risk factors prevalence and the AMI clinical course particularly at the level of delivery of health care services. There is almost no information from the region of Central Asia where over 50 million people are living. In our research, we have presented some findings demonstrating the peculiar features of outcomes, risk factors and treatment of AMI in women in Uzbekistan (the Central Asian country of the former Soviet Union) where the situation is, as a whole, similar to that one in neighboring countries (Kyrgyzstan, Turkmenia, Tajikistan and Kazakhstan). More and more information is being published on the fundamental differences in the physiology of sexes besides the reproductive system, these differences are increasing with age. High incidence of hypertension and dyslipidemia draws attention in these data. There is some prevalence of atypical AMI cases that agrees with the findings of some researchers (Hemingway et al., 2008; Volkov et al., 2010; Zaman et al., 2010). Prevalence of atypical complaints of women with ischemia is associated with microvascular and/or angiospastic angina pectoris. It is this pathophysiological mechanism of myocardium ischemia that occurs more often in women than in men population. We believe that later admission of AMI women to hospital is of special importance that probably is associated with both the females physiology (better tolerance of pain syndrome, not evident AMI onset) and social status. Rather low lethality rate attracts attention, too; it is comparable to the global data. However, the rates of MI recurrence and development of relapsing angina pectoris are much higher (except for China). Probably this is also due to late admission of patients and insufficient application of reperfusion techniques. Conclusion The peculiar features of acute myocardial infarction in women living in Central Asia are higher frequency of MI with no Q wave, less compliance with dislipidemia therapy against the background of greater obesity. Women are seeking medical aid four hours later than men; they have a higher percent of atypical MI forms. The main end point, for our opinion, is that reasons of differences between men and women in the region lie mostly in social sphere (late arriving, non-treated dislipidemia and AH) than in physiological peculiarities. In-hospital outcomes in males and females did not differ significantly due to the common tendency to late admission to hospital and a few revascularization interventions. References Alfredsson, J., Stenestrand, U., Wallentin, L., Gender differences in management and outcome in non- ST-elevation acute coronary syndrome, Heart, Vol.93, pp Gupta, R., Gupta, V., Meta-analysis of coronary heart disease prevalence in India, Indian Heart J., Vol.48, pp
6 Hemingway, H., Langenberg, C., Damant, J., Prevalence of angina in women versus men a systematic review and meta-analysis of international variations across 31 countries, Circulation, Vol.117, pp Hochman, J., Tamis, J., Thompson, T. et al., Sex, clinical presentation, and outcome in patients with acute coronary syndromes, N Engl J Med, Vol.341, pp Jiang, S., Ji, X., Zhang, C., Wang, X. et al., Impact of Chinese guidelines for management of patients with acute myocardial infarction on outcomes of hospitalized patients, Chinese Medical Journal, Vol.119(1), pp Rathore, S., Wang, Y., Radford, M. et al., Sex differences in cardiac catheterization after acute myocardial infarction: the role of procedure appropriateness, Ann Iintern Med., Vol.137, pp Shaw, L., Bairey, M., Pepine, C. et al., Insights from the NHLBI-Sponsored Women s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies, J Am Coll Cardiol., Vol. 47, pp.s4-s20. Sheifer, S., Canos, M., Weinfurt, K., Arora U. et al., Sex differences in coronary artery size assessed by intravascular ultrasound, Am Heart J., Vol.139, pp Vaccarino, V., Parsons, L., Every, N., Barron, H., Krumholz, H., Sex-based differences in early mortality after myocardial infarction, N Engl J Med., Vol.341, pp Volkov, V., Isaeva, A., Diagnostic and prognostic significance of well-defined evaluation of pain syndrome in women with cardiac ischemia, Liki Ukrainin., Vol.2(138), pp Yusuf, S, Ounpuu, S, Anand, S., Global burden of cardiovascular disease: A review of evidence, in: Coronary Artery Disease in Indians: A Global Perspective, Mumbai: Cardiological Society of India, pp Zaman, J., Junghans, C., Sekhri, N., 2008 Presentation of stable angina pectoris among women and South Asian people, CMAJ., 179(7), pp
APPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationPatient characteristics Intervention Comparison Length of followup
ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationRole of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University
Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationStudy of clinical presentations of acute myocardial infarction in Indian Population
Original article: Study of clinical presentations of acute myocardial infarction in Indian Population *Dr Aakash R Badgujar, **Dr Vijay K Joglekar *Department of Medicine, GMC, Mumbai **Head of Department,
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationAcute Myocardial Infarction. Willis E. Godin D.O., FACC
Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationA Multicenter Randomized Trial of Immediate Versus Delayed Invasive Strategy in Patients with Non-ST Elevation ACS
Angioplasty to Blunt the rise Of troponin in Acute coronary syndromes Randomized for an immediate or Delayed intervention A Multicenter Randomized Trial of Immediate Versus Delayed Invasive Strategy in
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationAn update on the management of UA / NSTEMI. Michael H. Crawford, MD
An update on the management of UA / NSTEMI Michael H. Crawford, MD New ACC/AHA Guidelines 2007 What s s new in the last 5 years CT imaging advances Ascendancy of troponin and BNP Clarification of ACEI/ARB
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationST-elevation myocardial infarctions (STEMIs)
Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationStress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh
Stress ECG is still Viable in 2016 Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG Do we still need stress ECG with all the advances we have in the CV field?
More informationTHE INCIDENCE OF PECTORIS ANGINA POST-ACUTE MYOCARDIAL INFARCTION IN ROMANIA RO-STEMI DATABASE
THE INCIDENCE OF PECTORIS ANGINA POST-ACUTE MYOCARDIAL INFARCTION IN ROMANIA RO-STEMI DATABASE Catalina Liliana CALIN PhD, Associate Professor University of Medicine and Pharmacy Carol Davila, Bucharest,
More informationAcute Myocardial Infarction: Difference in the Treatment between Men and Women
Quality Assurance in Hcahh Can, Vol. 5, No. 3, pp. 261-265,1993 Printed in Great Britain 1040-6166/93 $6.00 + 0.00 1993 Pergamon Press Ltd Acute Myocardial Infarction: Difference in the Treatment between
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationJournal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00643-9 Early
More informationBelinda Green, Cardiologist, SDHB, 2016
Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens
More informationAcute Coronary Syndromes
Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management
More informationCase Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA
Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationINTRODUCTION. Key Words:
Original Article Acta Cardiol Sin 2017;33:377 383 doi: 10.6515/ACS20170126A Percutaneous Coronary Intervention Predictors of Mortality in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome
More informationTIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS
European Heart Journal (2005) 26, 865 872 doi:10.1093/eurheartj/ehi187 Clinical research TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS
More informationLearning Objectives. Epidemiology of Acute Coronary Syndrome
Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet
More informationDownloaded from:
Annemans, L; Danchin, N; Van de Werf, F; Pocock, S; Licour, M; Medina, J; Bueno, H (2016) Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis
More informationMedicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
More informationDO NOT SUBMIT OR FAX THIS PAGE TO COR F M L DD MM YY
DO NOT SUBMIT OR FAX THIS PAGE TO COR Patient # Patient Initials of Birth Medical Record Number F M L DD MM YY Patient Name Address Telephone (home) Telephone (work) Expected 6-month Follow-up Family Physician
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More information2010 ACLS Guidelines. Primary goals of therapy for patients
2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in
More informationManagement of Acute Myocardial Infarction
Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationWhat s new in cardiovascular disease risk assessment and management for primary care clinicians
Cardiovascular system What s new in cardiovascular disease risk assessment and management for primary care clinicians The recently released 2018 Cardiovascular Disease Risk Assessment and Management for
More informationClinical presentation, gender and age profile of acute coronary syndrome - multicentre observational analysis in Vijayapur in North Karnataka
Original article Clinical presentation, gender and age profile of acute coronary syndrome - multicentre observational analysis in Vijayapur in North Karnataka Satish Talikoti 1, Nijora Deka 2 1Assistant
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial
compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial Outcomes in patients with and planned PCI Ph.Gabriel Steg*, Stefan James, Robert A
More informationAcute Coronary Syndrome
ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to
More informationUnstable angina and NSTEMI
Issue date: March 2010 Unstable angina and NSTEMI The early management of unstable angina and non-st-segment-elevation myocardial infarction This guideline updates and replaces recommendations for the
More informationChest Pain. Dr Robert Huggett Consultant Cardiologist
Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the
More informationCondition/Procedure Measure Compliance Criteria Reference Attribution Method
Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More informationTIMI and GRACE Risk Scores Predict Both Short-Term and Long-Term Outcomes in Chinese Patients with Acute Myocardial Infarction
Original Article Acta Cardiol Sin 2018;34:4 12 doi: 10.6515/ACS.201801_34(1).20170730B Coronary Artery Disease TIMI and GRACE Risk Scores Predict Both Short-Term and Long-Term Outcomes in Chinese Patients
More informationALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic
1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationBackground- Methods-
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE- Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data Jing Li, Xi Li, Qing
More informationMYOCARDIALINFARCTION. By: Kendra Fischer
MYOCARDIALINFARCTION By: Kendra Fischer Outline Definition Epidemiology Clinical Aspects Treatment Effects of Exercise Exercise Testing Exercise Rx Summary and Conclusions References Break it down MYOCARDIAL
More informationCompliance of pharmacological treatment for non-st-elevation acute coronary syndromes with contemporary guidelines: influence on outcomes
Original Article Compliance of pharmacological treatment for non-st-elevation acute coronary syndromes with contemporary guidelines: influence on outcomes Hélder Dores 1, Carlos Aguiar 1, Jorge Ferreira
More informationTICAGRELOR VERSUS CLOPIDOGREL AFTER THROMBOLYTIC THERAPY IN PATIENTS WITH ST- ELEVATION MYOCARDIAL INFARCTION: A RANDOMIZED CLINICAL TRIAL
TICAGRELOR VERSUS CLOPIDOGREL AFTER THROMBOLYTIC THERAPY IN PATIENTS WITH ST- ELEVATION MYOCARDIAL INFARCTION: A RANDOMIZED CLINICAL TRIAL Otavio Berwanger, MD, PhD - On behalf of the TREAT Trial Steering
More informationWhy and How Should We Switch Clopidogrel to Prasugrel?
Case Presentation Why and How Should We Switch Clopidogrel to Prasugrel? Shaul Atar Western Galilee Medical Center Nahariya, ISRAEL Case Description A 67 Y. Old Pt. admitted to IM with anginal CP. DM,
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationDurlaza. Durlaza (aspirin) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.13 Subject: Durlaza Page: 1 of 4 Last Review Date: September 15, 2016 Durlaza Description Durlaza
More informationTransfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem
Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927
More informationOUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More information12 Lead EKG Chapter 4 Worksheet
Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More informationDISCUSSION QUESTION - 1
CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationSubsequent management and therapies
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial
compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationXi Li, Jing Li, Frederick A Masoudi, John A Spertus, Zhenqiu Lin, Harlan M Krumholz, Lixin Jiang for the China PEACE Collaborative Group
China PEACE risk estimation tool for inhospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy Xi Li, Jing Li, Frederick A Masoudi, John
More informationCardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 10, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 10, 2009 2009 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/09/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2009.07.008 Outcomes
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationManagement of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018
Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management
More informationTransient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction
Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology
More informationConsensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationCoronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study
Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Xin Zheng, MD, PhD; Jeptha P. Curtis, MD; Shuang Hu, PhD; YongfeiWang,
More informationOtamixaban for non-st-segment elevation acute coronary syndrome
Otamixaban for non-st-segment elevation acute coronary syndrome September 2011 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationAsian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017
Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute
More informationInter-regional differences and outcome in unstable angina
European Heart Journal (2000) 21, 1433 1439 doi:10.1053/euhj.1999.1983, available online at http://www.idealibrary.com on Inter-regional differences and outcome in unstable angina Analysis of the International
More informationImaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference
More informationAppendix: ACC/AHA and ESC practice guidelines
Appendix: ACC/AHA and ESC practice guidelines Definitions for guideline recommendations and level of evidence Recommendation Class I Class IIa Class IIb Class III Level of evidence Level A Level B Level
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1
More informationCoronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N
Coronary Heart Disease Raja Nursing Instructor RN, DCHN, Post RN. BSc.N 31/03/2016 Objectives Define coronary heart disease (CHD). Identify the causes and risk factors of CHD Discuss the pathophysiological
More informationSTEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology
STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post
More information2012 Core Measures. Acute Myocardial Infarction (AMI)
2012 Core Measures Acute Myocardial Infarction (AMI) Aspirin at Arrival Aspirin Prescribed at Discharge Angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for left ventricular
More informationGSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationStudy of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri
Original Research Article Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri P. Sasikumar * Department of General Medicine, Govt.
More informationShould All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?
Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Avi Shimony, MD, FESC Cardiology Division Soroka University Medical Center Ben-Gurion University, Beer-Sheva Disclosure
More informationSTABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators
STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY Harvey D White on behalf of The STABILITY Investigators Lipoprotein- associated Phospholipase A 2 (Lp-PLA 2 ) activity:
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More informationDUKECATHR Dataset Dictionary
DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of
More informationThe Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University
The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University Expert Opinions CCS Vancouver, BC October 23, 2011 Overview of ACS Epidemiology: Global
More informationA Report From the Second National Registry of Myocardial Infarction (NRMI-2)
1240 JACC Vol. 31, No. 6 Clinical Experience With Primary Percutaneous Transluminal Coronary Angioplasty Compared With Alteplase (Recombinant Tissue-Type Plasminogen Activator) in Patients With Acute Myocardial
More informationPrasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center
Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center Hospitalizations in the U.S. Due to ACS Acute Coronary Syndromes
More information